tiprankstipranks
Equillium Inc (EQ)
NASDAQ:EQ
US Market
EQ
Equillium
RESEARCH TOOLSreports
Want to see EQ full AI Analyst Report?

Equillium (EQ) Stock Forecast & Price Target

849 Followers
See the Price Targets and Ratings of:

EQ Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Equillium
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

EQ Stock 12 Month Forecast

Average Price Target

$11.60
▲(432.11% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Equillium in the last 3 months. The average price target is $11.60 with a high forecast of $20.00 and a low forecast of $7.00. The average price target represents a 432.11% change from the last price of $2.18.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","21":"$21","-1":"-$1","4.5":"$4.5","15.5":"$15.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.6,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$11.60</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$7.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,4.5,10,15.5,21],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.205,3.573846153846154,4.942692307692308,6.311538461538462,7.680384615384616,9.049230769230771,10.418076923076924,11.78692307692308,13.155769230769232,14.524615384615386,15.89346153846154,17.262307692307694,18.63115384615385,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.205,2.9276923076923076,3.650384615384615,4.373076923076923,5.09576923076923,5.818461538461538,6.541153846153846,7.263846153846154,7.986538461538461,8.709230769230768,9.431923076923077,10.154615384615383,10.877307692307692,{"y":11.6,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2.205,2.573846153846154,2.9426923076923077,3.3115384615384613,3.6803846153846154,4.049230769230769,4.418076923076923,4.786923076923077,5.155769230769231,5.524615384615385,5.893461538461539,6.262307692307692,6.631153846153846,{"y":7,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.72,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.41,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.86,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1.51,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.92,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.04,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.08,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.08,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.04,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.2,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.205,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$20.00Average Price Target$11.60Lowest Price Target$7.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on EQ
Adam Walsh
Roth MKM
Roth MKM
$12
Buy
450.46%
Upside
Reiterated
09/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Cantor Fitzgerald Analyst forecast on EQ
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$10
Buy
358.72%
Upside
Reiterated
08/14/26
Equillium (EQ) Gets a Buy from Cantor Fitzgerald
Oppenheimer Analyst forecast on EQ
Leland Gershell
Oppenheimer
Oppenheimer
$7
Buy
221.10%
Upside
Assigned
08/14/26
Oppenheimer Sticks to Their Buy Rating for Equillium (EQ)
Clear Street Analyst forecast on EQ
Kaveri Pohlman
Clear Street
Clear Street
$9
Buy
312.84%
Upside
Reiterated
08/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Piper Sandler Analyst forecast on EQ
Yasmeen Rahimi
Piper Sandler
Piper Sandler
$20
Buy
817.43%
Upside
Initiated
07/13/26
Equillium initiated with an Overweight at Piper SandlerEquillium initiated with an Overweight at Piper Sandler
B. Riley Securities Analyst forecast on EQ
William Wood
B. Riley Securities
B. Riley Securities
$6
Buy
175.23%
Upside
Reiterated
06/02/26
Equillium (EQ) Receives a Buy from B. Riley Securities
Leerink Partners Analyst forecast on EQ
Thomas Smith
Leerink Partners
Leerink Partners
$6
Buy
175.23%
Upside
Upgraded
05/28/26
Equillium upgraded to Outperform from Market Perform at LeerinkEquillium upgraded to Outperform from Market Perform at Leerink
Stifel Nicolaus Analyst forecast on EQ
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$5
Buy
129.36%
Upside
Reiterated
05/28/26
Analysts' Top Healthcare Picks: Aligos Therapeutics (ALGS), Equillium (EQ)
Raymond James Analyst forecast on EQ
Martin Auster
Raymond James
Raymond James
$6→$7
Buy
221.10%
Upside
Reiterated
05/28/26
Equillium price target raised to $7 from $6 at Raymond JamesEquillium price target raised to $7 from $6 at Raymond James
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Roth MKM Analyst forecast on EQ
Adam Walsh
Roth MKM
Roth MKM
$12
Buy
450.46%
Upside
Reiterated
09/04/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Cantor Fitzgerald Analyst forecast on EQ
Steven Seedhouse
Cantor Fitzgerald
Cantor Fitzgerald
$10
Buy
358.72%
Upside
Reiterated
08/14/26
Equillium (EQ) Gets a Buy from Cantor Fitzgerald
Oppenheimer Analyst forecast on EQ
Leland Gershell
Oppenheimer
Oppenheimer
$7
Buy
221.10%
Upside
Assigned
08/14/26
Oppenheimer Sticks to Their Buy Rating for Equillium (EQ)
Clear Street Analyst forecast on EQ
Kaveri Pohlman
Clear Street
Clear Street
$9
Buy
312.84%
Upside
Reiterated
08/03/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Piper Sandler Analyst forecast on EQ
Yasmeen Rahimi
Piper Sandler
Piper Sandler
$20
Buy
817.43%
Upside
Initiated
07/13/26
Equillium initiated with an Overweight at Piper SandlerEquillium initiated with an Overweight at Piper Sandler
B. Riley Securities Analyst forecast on EQ
William Wood
B. Riley Securities
B. Riley Securities
$6
Buy
175.23%
Upside
Reiterated
06/02/26
Equillium (EQ) Receives a Buy from B. Riley Securities
Leerink Partners Analyst forecast on EQ
Thomas Smith
Leerink Partners
Leerink Partners
$6
Buy
175.23%
Upside
Upgraded
05/28/26
Equillium upgraded to Outperform from Market Perform at LeerinkEquillium upgraded to Outperform from Market Perform at Leerink
Stifel Nicolaus Analyst forecast on EQ
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$5
Buy
129.36%
Upside
Reiterated
05/28/26
Analysts' Top Healthcare Picks: Aligos Therapeutics (ALGS), Equillium (EQ)
Raymond James Analyst forecast on EQ
Martin Auster
Raymond James
Raymond James
$6→$7
Buy
221.10%
Upside
Reiterated
05/28/26
Equillium price target raised to $7 from $6 at Raymond JamesEquillium price target raised to $7 from $6 at Raymond James
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
BTSGBrightSpring Health Services, Inc.
GPCRStructure Therapeutics, Inc. Sponsored ADR
BLTEBelite Bio, Inc. ADR
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Equillium

3 Months
Thomas SmithLeerink Partners
Success Rate
6/17 ratings generated profit
35%
Average Return
+9.62%
Copying Thomas Smith's trades and holding each position for 3 Months would result in 35.29% of your transactions generating a profit, with an average return of +9.62% per trade.
1 Year
Thomas SmithLeerink Partners
Success Rate
5/17 ratings generated profit
29%
Average Return
-0.44%
Copying Thomas Smith's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -0.44% per trade.
2 Years
Adam WalshRoth MKM
Success Rate
1/7 ratings generated profit
14%
Average Return
-15.56%
Copying Adam Walsh's trades and holding each position for 2 Years would result in 14.29% of your transactions generating a profit, with an average return of -15.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EQ Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
14
16
13
11
8
Buy
0
0
0
0
0
Hold
0
0
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
14
16
14
12
9
In the current month, EQ has received 8 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. EQ average Analyst price target in the past 3 months is 11.60.
Each month's total comprises the sum of three months' worth of ratings.

EQ Financial Forecast

EQ Earnings Forecast

Next quarter’s earnings estimate for EQ is -$0.05 with a range of -$0.06 to -$0.04. The previous quarter’s EPS was -$0.04. EQ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year EQ has Performed in-line its overall industry.
Next quarter’s earnings estimate for EQ is -$0.05 with a range of -$0.06 to -$0.04. The previous quarter’s EPS was -$0.04. EQ beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year EQ has Performed in-line its overall industry.

EQ Sales Forecast

Next quarter’s sales forecast for EQ is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. EQ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year EQ has Performed in-line its overall industry.
Next quarter’s sales forecast for EQ is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. EQ beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year EQ has Performed in-line its overall industry.

EQ Stock Forecast FAQ

What is EQ’s average 12-month price target, according to analysts?
Based on analyst ratings, Equillium Inc’s 12-month average price target is 11.60.
    What is EQ’s upside potential, based on the analysts’ average price target?
    Equillium Inc has 432.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is EQ a Buy, Sell or Hold?
          Equillium Inc has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Equillium Inc’s price target?
            The average price target for Equillium Inc is 11.60. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $20.00 ,the lowest forecast is $7.00. The average price target represents 432.11% Increase from the current price of $2.18.
              What do analysts say about Equillium Inc?
              Equillium Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of EQ?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.